Purchases and Sales Made in Q1 2025 in Acumen Pharmaceuticals, Inc. (ABOS)
This table provides information about the institutional ownership of Acumen Pharmaceuticals, Inc. (ABOS) during Q1 2025. The information is specifically focused on institutions that hold shares of Acumen Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2025
Q1 2025
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-69K- 22.89% |
$75.9K - $131K
|
232K
$279K
|
|
|
May 12, 2025
Q1 2025
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-106K- 11.26% |
$116K - $201K
|
832K
$999K
|
|
|
May 15, 2025
Q1 2025
|
Morgan Stanley
New York, NY |
SELL
|
- |
-114K- 42.66% |
$125K - $216K
|
153K
$183K
|
|
|
May 13, 2025
Q1 2025
|
Franklin Resources Inc
San Mateo, CA |
SELL
|
- |
-132K- 4.02% |
$145K - $250K
|
3.14M
$3.77M
|
|
|
May 15, 2025
Q1 2025
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-210K- 15.58% |
$230K - $398K
|
1.14M
$1.36M
|